Functional Links Between Aβ Toxicity, Endocytic Trafficking, and Alzheimer’s Disease Risk Factors in Yeast

The use of yeast as a model organism reveals cellular factors involved in beta-amyloid toxicity. Aβ (beta-amyloid peptide) is an important contributor to Alzheimer’s disease (AD). We modeled Aβ toxicity in yeast by directing the peptide to the secretory pathway. A genome-wide screen for toxicity modifiers identified the yeast homolog of phosphatidylinositol binding clathrin assembly protein (PICALM) and other endocytic factors connected to AD whose relationship to Aβ was previously unknown. The factors identified in yeast modified Aβ toxicity in glutamatergic neurons of Caenorhabditis elegans and in primary rat cortical neurons. In yeast, Aβ impaired the endocytic trafficking of a plasma membrane receptor, which was ameliorated by endocytic pathway factors identified in the yeast screen. Thus, links between Aβ, endocytosis, and human AD risk factors can be ascertained with yeast as a model system.

[1]  Christoph Lange,et al.  Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. , 2008, American journal of human genetics.

[2]  B. Penke,et al.  Amyloid β‐peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease , 2004 .

[3]  K D Wittrup,et al.  Secretion efficiency in Saccharomyces cerevisiae of bovine pancreatic trypsin inhibitor mutants lacking disulfide bonds is correlated with thermodynamic stability. , 1998, Biochemistry.

[4]  P. Toselli,et al.  Structure and function analysis of the CMS/CIN85 protein family identifies actin-bundling properties and heterotypic-complex formation , 2007, Journal of Cell Science.

[5]  M. Arévalo-Rodríguez,et al.  An improved system for estradiol-dependent regulation of gene expression in yeast , 2007, Microbial cell factories.

[6]  Jürgen Götz,et al.  Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.

[7]  Michael S. Wolfe,et al.  Presenilin: Running with Scissors in the Membrane , 2007, Cell.

[8]  F. LaFerla Pathways linking Abeta and tau pathologies. , 2010, Biochemical Society transactions.

[9]  D. G. Clark,et al.  Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.

[10]  L. Kiemeney,et al.  Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.

[11]  Nick C Fox,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.

[12]  A. Adler,et al.  The Rsp5 Ubiquitin Ligase Binds to and Ubiquitinates Members of the Yeast CIN85-Endophilin Complex, Sla1-Rvs167* , 2004, Journal of Biological Chemistry.

[13]  S. Lindquist,et al.  Screening for Amyloid Aggregation by Semi-Denaturing Detergent-Agarose Gel Electrophoresis , 2008, Journal of visualized experiments : JoVE.

[14]  Jason J. Corneveaux,et al.  CR1 is associated with amyloid plaque burden and age‐related cognitive decline , 2011, Annals of neurology.

[15]  M. Kaksonen,et al.  PtdIns(4,5)P2 turnover is required for multiple stages during clathrin- and actin-dependent endocytic internalization , 2007, The Journal of cell biology.

[16]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[17]  Jonathan S. Weissman,et al.  Construction, Verification and Experimental Use of Two Epitope-Tagged Collections of Budding Yeast Strains , 2005, Comparative and functional genomics.

[18]  David A. Bennett,et al.  Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles , 2009, Neurology.

[19]  Kristina D. Micheva,et al.  Identification and Characterization of a Nerve Terminal-enriched Amphiphysin Isoform* , 1997, The Journal of Biological Chemistry.

[20]  J. Rogers,et al.  hORFeome v3.1: A resource of human open reading frames representing over 10,000 human genes , 2007, Genomics.

[21]  J. Bessereau,et al.  [C. elegans: of neurons and genes]. , 2003, Medecine sciences : M/S.

[22]  Songsong Cao,et al.  Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model , 2008, Proceedings of the National Academy of Sciences.

[23]  S. Lindquist,et al.  A suite of Gateway® cloning vectors for high‐throughput genetic analysis in Saccharomyces cerevisiae , 2007, Yeast.

[24]  Michael R Dores,et al.  Interaction between Epsin/Yap180 adaptors and the scaffolds Ede1/Pan1 is required for endocytosis. , 2008, Molecular biology of the cell.

[25]  V. Haucke,et al.  Clathrin‐Mediated Endocytosis at Synapses , 2007, Traffic.

[26]  S. Lindquist,et al.  Hsp104 Catalyzes Formation and Elimination of Self-Replicating Sup35 Prion Conformers , 2004, Science.

[27]  H. Pelham Control of protein exit from the endoplasmic reticulum. , 1989, Annual review of cell biology.

[28]  Joshua A. Kritzer,et al.  Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson’s disease models , 2010, Disease Models & Mechanisms.

[29]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[30]  Shaomin Li,et al.  Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.

[31]  J. Hay,et al.  α-Synuclein Delays Endoplasmic Reticulum (ER)-to-Golgi Transport in Mammalian Cells by Antagonizing ER/Golgi SNAREs , 2010, Molecular biology of the cell.

[32]  P. Bosco,et al.  Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease , 2009, Nature Genetics.

[33]  Zhaohui S. Qin,et al.  A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.

[34]  S. Brenner The genetics of Caenorhabditis elegans. , 1974, Genetics.

[35]  D. Bennett,et al.  Intermediate Phenotypes Identify Divergent Pathways to Alzheimer's Disease , 2010, PloS one.

[36]  D. Bozyczko‐Coyne,et al.  CEP‐1347/KT‐7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Aβ‐induced cortical neuron apoptosis , 2001, Journal of neurochemistry.

[37]  L. Martin,et al.  Long-term culture of mouse cortical neurons as a model for neuronal development, aging, and death. , 2002, Journal of neurobiology.

[38]  S. Yan,et al.  Role of mitochondrial amyloid-beta in Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[39]  Roger M. Nitsch,et al.  Intracellular Aβ and cognitive deficits precede β-amyloid deposition in transgenic arcAβ mice , 2007, Neurobiology of Aging.

[40]  R. Nitsch,et al.  Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice. , 2007, Neurobiology of aging.

[41]  M. Vestling,et al.  Amyloid-β Oligomer Specificity Mediated by the IgM Isotype – Implications for a Specific Protective Mechanism Exerted by Endogenous Auto-Antibodies , 2010, PloS one.

[42]  S. Lindquist,et al.  α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models , 2006, Science.

[43]  C. Link,et al.  Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Trojanowski,et al.  Targeting Amyloid-β Peptide (Aβ) Oligomers by Passive Immunization with a Conformation-selective Monoclonal Antibody Improves Learning and Memory in Aβ Precursor Protein (APP) Transgenic Mice* , 2006, Journal of Biological Chemistry.

[45]  M. Vidal,et al.  C. elegans ORFeome version 3.1: increasing the coverage of ORFeome resources with improved gene predictions. , 2004, Genome research.

[46]  S. Lindquist,et al.  α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity , 2009, Nature Genetics.

[47]  D. Selkoe,et al.  The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. , 2000, Biochemistry.

[48]  S. Lindquist,et al.  Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker's yeast? , 2010, Nature Reviews Neuroscience.

[49]  B. Barneda-Zahonero,et al.  Soluble Oligomers of Amyloid-β Peptide Disrupt Membrane Trafficking of α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Contributing to Early Synapse Dysfunction* , 2011, The Journal of Biological Chemistry.

[50]  Nick C Fox,et al.  Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .

[51]  E. Koo,et al.  Amyloid Precursor Protein Trafficking, Processing, and Function* , 2008, Journal of Biological Chemistry.

[52]  J. Fleming,et al.  Basic culture methods. , 1995, Methods in cell biology.

[53]  J. Haines,et al.  ApoE-4 and Age at Onset of Alzheimer's Disease , 1997, Neurology.

[54]  Nick C Fox,et al.  Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease , 2011, Nature Genetics.

[55]  Sudha Seshadri,et al.  Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.

[56]  Steve D. M. Brown,et al.  α-Synuclein impairs macroautophagy: implications for Parkinson’s disease , 2010, The Journal of cell biology.

[57]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[58]  G. Gibson,et al.  A mitocentric view of Alzheimer's disease suggests multi-faceted treatments. , 2010, Journal of Alzheimer's disease : JAD.

[59]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[60]  S. Lindquist,et al.  Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology , 2003, Science.

[61]  A. Linstedt Faculty Opinions recommendation of Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. , 2006 .